Literature DB >> 2467991

The herpes simplex virus immediate-early protein, ICP4, is required to potentiate replication of human immunodeficiency virus in CD4+ lymphocytes.

M A Albrecht1, N A DeLuca, R A Byrn, P A Schaffer, S M Hammer.   

Abstract

The interaction of human immunodeficiency virus (HIV) and herpes simplex virus (HSV) was investigated in an acute whole-virus coinfection system. CD4+ lymphoid CEM cells were infected with HIV-1 and, 24 h later, superinfected with HSV-1 (strain KOS) or HSV mutants possessing defined deletions in genes specifying the immediate-early transcriptional regulatory proteins ICP0, ICP4, or ICP27. Marked potentiation of HIV replication was demonstrated with the KOS strain, the ICP0 mutant, and the ICP27 mutant, but not with the ICP4 mutant, indicating that ICP4 is essential and ICP0 and ICP27 are nonessential for this effect. These studies demonstrate that HSV can be a potent stimulator of HIV replication and gene expression in coinfected CD4+ cells through the activity of the HSV regulatory protein ICP4.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2467991      PMCID: PMC250596     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  Stimulation of expression of a herpes simplex virus DNA-binding protein by two viral functions.

Authors:  M P Quinlan; D M Knipe
Journal:  Mol Cell Biol       Date:  1985-05       Impact factor: 4.272

2.  Identification of multiple cytomegalovirus strains in homosexual men with acquired immunodeficiency syndrome.

Authors:  S A Spector; K K Hirata; T R Newman
Journal:  J Infect Dis       Date:  1984-12       Impact factor: 5.226

3.  Activation and suppression of herpes simplex virus in a human T lymphoid cell line.

Authors:  S M Hammer; B S Richter; M S Hirsch
Journal:  J Immunol       Date:  1981-07       Impact factor: 5.422

4.  Death in the AIDS patient: role of cytomegalovirus.

Authors:  A M Macher; C M Reichert; S E Straus; D L Longo; J Parrillo; H C Lane; A S Fauci; A H Rook; J F Manischewitz; G V Quinnan
Journal:  N Engl J Med       Date:  1983-12-08       Impact factor: 91.245

5.  Herpes simplex virus type 1 ICP27 deletion mutants exhibit altered patterns of transcription and are DNA deficient.

Authors:  A M McCarthy; L McMahan; P A Schaffer
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

6.  Abnormal properties of an immediate early polypeptide in cells infected with the herpes simplex virus type 1 mutant tsK.

Authors:  C M Preston
Journal:  J Virol       Date:  1979-11       Impact factor: 5.103

7.  Herpesvirus infections in the acquired immune deficiency syndrome.

Authors:  G V Quinnan; H Masur; A H Rook; G Armstrong; W R Frederick; J Epstein; J F Manischewitz; A M Macher; L Jackson; J Ames
Journal:  JAMA       Date:  1984-07-06       Impact factor: 56.272

8.  Cytomegalovirus infections in homosexual men. An epidemiological study.

Authors:  L Mintz; W L Drew; R C Miner; E H Braff
Journal:  Ann Intern Med       Date:  1983-09       Impact factor: 25.391

9.  Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma.

Authors:  B J Poiesz; F W Ruscetti; A F Gazdar; P A Bunn; J D Minna; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

10.  Trans activation of transcription by herpes virus products: requirement for two HSV-1 immediate-early polypeptides for maximum activity.

Authors:  R D Everett
Journal:  EMBO J       Date:  1984-12-20       Impact factor: 11.598

View more
  34 in total

Review 1.  Human herpesvirus 6.

Authors:  D K Braun; G Dominguez; P E Pellett
Journal:  Clin Microbiol Rev       Date:  1997-07       Impact factor: 26.132

2.  Activation of the human immunodeficiency virus type 1 long terminal repeat by vaccinia virus.

Authors:  K A Stellrecht; K Sperber; B G Pogo
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

3.  The Epstein-Barr virus BRLF1 immediate-early gene product transactivates the human immunodeficiency virus type 1 long terminal repeat by a mechanism which is enhancer independent.

Authors:  E B Quinlivan; E Holley-Guthrie; E C Mar; M S Smith; S Kenney
Journal:  J Virol       Date:  1990-04       Impact factor: 5.103

Review 4.  Infectious co-factors in HIV-1 transmission herpes simplex virus type-2 and HIV-1: new insights and interventions.

Authors:  Ruanne V Barnabas; Connie Celum
Journal:  Curr HIV Res       Date:  2012-04       Impact factor: 1.581

5.  Transactivation of human T-cell leukemia virus type 1 by herpes simplex virus type 1.

Authors:  S Israel; M Mendelovitz; A Honigman
Journal:  Virus Genes       Date:  1995-02       Impact factor: 2.332

6.  The presence of tat protein or tumor necrosis factor alpha is critical for herpes simplex virus type 1-induced expression of human immunodeficiency virus type 1.

Authors:  W Popik; P M Pitha
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

7.  Nuclear sequestration of cellular chaperone and proteasomal machinery during herpes simplex virus type 1 infection.

Authors:  April D Burch; Sandra K Weller
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

Review 8.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03

9.  Human cytomegalovirus inhibits human immunodeficiency virus replication in cells productively infected by both viruses.

Authors:  V Koval; C Clark; M Vaishnav; S A Spector; D H Spector
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

10.  Sequential serological studies of homosexual men with and without HIV infection. Epstein-Barr virus activation preceding and following HIV seroconversion.

Authors:  A Schattner; N Hanuka; B Sarov; I Sarov; Z Handzel; Z Bentwich
Journal:  Clin Exp Immunol       Date:  1991-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.